U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020564

Expand all

EPIVIR (LAMIVUDINE)
150MG
Marketing Status: Prescription
Active Ingredient: LAMIVUDINE
Proprietary Name: EPIVIR
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020564
Product Number: 001
Approval Date: Nov 17, 1995
Applicant Holder Full Name: VIIV HEALTHCARE CO
Marketing Status:  Prescription
Patent and Exclusivity Information
EPIVIR (LAMIVUDINE)
300MG
Marketing Status: Prescription
Active Ingredient: LAMIVUDINE
Proprietary Name: EPIVIR
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020564
Product Number: 003
Approval Date: Jun 24, 2002
Applicant Holder Full Name: VIIV HEALTHCARE CO
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top